作者: Jill P Pell , Andrew Walker , Stuart M Cobbe
DOI: 10.1097/HCO.0B013E3280118FEC
关键词:
摘要: Purpose of review To discuss the clinical effectiveness, public health impact and cost-effectiveness access defibrillation. Recent findings High rates survival from prehospital ventricular fibrillation have been documented in patients treated by first responders using automated external defibrillators. The recent Public Access Defibrillation trial demonstrated a doubling cardiac arrest community units where volunteers trained cardiopulmonary resuscitation were additionally equipped with analysis has not yet published, previous analyses lacked full data on cost, outcome, or both. Data many sources indicate that defibrillator placement at sites an expected rate one per 5 years, as recommended American Heart Association, addresses only around 1-2% arrests, will minimal population survival. Summary While highly targeted provision defibrillators areas greatest risk, such casinos airports, may be cost-effective, it little level. Provision more widespread defibrillation to lower incidence is unlikely represent poorer value for money than alternative healthcare interventions coronary artery disease.